Nurse Practitioner · New Haven, CT
NPI
1528665213
Since 2020
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
20 York St
New Haven, CT, 06510
Phone (203) 688-4242
Groups this clinician bills Medicare through
Medicare paid, 2024
$16K
301 services
Medicare patients, 2024
166
Average age 77
Drug cost, 2024
$379K
1,668 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rebecca D Harrison was code 93264 (external electrocardiographic monitoring), 87 times for 56 patients. In total Rebecca D Harrison billed 301 services in 6 codes, and Medicare paid $16K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93264 External Electrocardiographic Monitoring | Facility | 87 | 56 | $21.80 | $1,897 |
| 99214 Office E&M - Established | Facility | 83 | 50 | $61.84 | $5,132 |
| 99214 Office E&M - Established | Office | 40 | 30 | $66.23 | $2,649 |
| 99215 Office E&M - Established | Facility | 37 | 22 | $92.12 | $3,408 |
| 99213 Office E&M - Established | Facility | 29 | 28 | $44.12 | $1,280 |
| 99213 Office E&M - Established | Office | 15 | 15 | $45.78 | $687 |
By year: 2022 $14K for 284 services; 2023 $17K for 303 services; 2024 $16K for 301 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rebecca D Harrison prescribed most often to Medicare patients was Warfarin Sodium, with 286 prescriptions and refills. In total Rebecca D Harrison wrote 1,668 Medicare prescriptions that cost $379K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Warfarin Sodium Generic | 286 | 701 | 109 | $2,844 |
| Spironolactone Generic | 187 | 482 | 75 | $1,300 |
| Bumetanide Generic | 153 | 385 | 73 | $23K |
| Entresto Sacubitril/Valsartan | 143 | 185 | 34 | $125K |
| Furosemide Generic | 120 | 296 | 61 | $784 |
| Torsemide Generic | 119 | 264 | 57 | $4,852 |
| Farxiga Dapagliflozin Propanediol | 116 | 243 | 37 | $135K |
| Metoprolol Succinate Generic | 99 | 245 | 41 | $1,161 |
| Carvedilol Generic | 70 | 148 | 27 | $517 |
| Potassium Chloride Generic | 51 | 100 | 20 | $1,260 |
| Jardiance Empagliflozin | 47 | 93 | 16 | $56K |
| Losartan Potassium Generic | 42 | 106 | 18 | $156 |
| Enoxaparin Sodium Generic | 35 | 35 | 20 | $2,587 |
| Metolazone Generic | 33 | 48 | 18 | $189 |
| Hydralazine Hcl Generic | 17 | 33 | Under 11 | $237 |
Brand drugs: 356 claims; generic drugs: 1,312 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Rebecca D Harrison were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.